BSEInsider Trading / SAST8h ago · 25 Sept 2026, 11:37 am
Intimation of Closure of Trading Window
Shilpa Medicare Ltd · 530549
✦ AI Summary
Shilpa Medicare Ltd has announced the closure of its trading window for all designated persons and their relatives, effective from 01 October 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ended 30 September 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shilpa Medicare Ltd - 530549 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
7896550f-9d06-4f5d-b214-cab734123886.pdf
View document text
Shilpa Medicare Limited
Corporate & Admin Office:
“Shilpa House”, # 12-6-214/A-1, Hyderabad Road,
Raichur – 584 135, Karnataka, India
Tel: +91-8532-238704, Fax: +91-8532-238876
Email: info@vbshilpa.com, Web: www.vbshilpa.com
CIN: L85110KA1987PLC008739
Date: 25 September 2026
To To
Corporate Relationship Department National Stock Exchange of India Limited
BSE Limited, Exchange Plaza, 5th Floor,
1st Floor, Rotunda Building, Plot No.C/1, G Block
P.J. Towers, Dalal Street, Bandra Kurla Complex, Bandra (E)
Mumbai – 400 001. Mumbai – 400 051.
Stock Code: BSE – 530549/ NSE – SHILPAMED
Dear Sir/Ma’am,
Sub: Intimation of Closure of Trading Window
Pursuant to the ‘Code of Conduct for Prohibition of Insider Trading, the Trading Window for dealing
in the securities of the Company shall remain closed for all the designated persons and their
immediate relatives, Connected Persons (including their relatives) as covered under the said Code
with effect from 01 October 2026, till 48 hours after the declaration of un-audited Financial
Results for quarter and half year ended 30 September 2026.
Accordingly, all Designated Persons of the Company are being advised not to trade in the securities
of the Company during the aforesaid period of closure of the Trading Window.
Please note that the date of the Board Meeting to be held for consideration of the unaudited
Financial Results of the Company for the quarter and half year ended September 30, 2026, shall be
communicated in due course.
This is for your information and records.
Thanking you,
For Shilpa Medicare Limited
Ritu Tiwary
Company Secretary & Compliance Officer